Miller V A, Reuter V, Scher H I
Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Urology. 1995 Jul;46(1):111-3. doi: 10.1016/S0090-4295(99)80174-5.
We describe a 67-year-old man with a history of Stage B1 adenocarcinoma of the prostate who was treated with iodine-125 implantation in 1985. His prostate-specific antigen values subsequently increased in conjunction with an intraprostatic recurrence. Biopsy revealed primary squamous cell carcinoma arising in the prostate; no adenocarcinomatous elements were noted.
我们描述了一名67岁男性,有前列腺B1期腺癌病史,于1985年接受碘-125植入治疗。随后他的前列腺特异性抗原值随前列腺内复发而升高。活检显示前列腺出现原发性鳞状细胞癌;未发现腺癌成分。